ロード中...
Electronic medical records-based comparison of glycemic control efficacy between sulfonylureas and dipeptidyl peptidase-4 inhibitors added on to metformin monotherapy in patients with type 2 diabetes
Sulfonylurea (SU) and dipeptidyl peptidase-4 (DPP-4) inhibitors are most common secondary agents that are added to metformin monotherapy. Real-world studies have become increasingly important in providing evidence of treatment effectiveness in clinical practice and real-world data could help appropr...
保存先:
| 出版年: | Transl Clin Pharmacol |
|---|---|
| 主要な著者: | , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Korean Society for Clinical Pharmacology and Therapeutics
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7781806/ https://ncbi.nlm.nih.gov/pubmed/33425803 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.12793/tcp.2020.28.e21 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|